Efficacy of Pirfenidone According to Dose in Patients with Idiopathic Pulmonary Fibrosis: A Prospective, Observational, Single-Center Cohort Study

Background: Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease with a poor prognosis. Pirfenidone is approved and widely used for the treatment of IPF and reduces lung function decline. The aim of this study was to evaluate the efficacy of different doses of pirfenidone for t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ho Young, Jung, So Young, Jang, Ji Hoon, Ko, Junghae, Kim, Dae-Wook, Her, Minyoung, Lee, Jae Ha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672649/
https://www.ncbi.nlm.nih.gov/pubmed/38004258
http://dx.doi.org/10.3390/life13112118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672649/
https://www.ncbi.nlm.nih.gov/pubmed/38004258
http://dx.doi.org/10.3390/life13112118

Ejemplares similares